Medical Affairs and Key Opinion Leader Engagement
J&J's pharmaceutical commercial model is built on Medical Affairs teams that engage oncologists, rheumatologists, gastroenterologists, and neurologists through clinical evidence generation, medical education programs, and advisory board relationships — ensuring that key opinion leaders who influence prescribing patterns in specialty therapeutics receive continuous, evidence-based communication about J&J products and pipeline relative to competing therapies.
Credo-Based Brand and Trust Marketing
J&J's Credo — placing patients, customers, employees, and communities before shareholders — functions as a brand foundation that differentiates the company from purely financial-performance-oriented competitors, particularly in payer, hospital, and regulatory relationships where institutional trust and long-term partnership orientation are valued alongside product efficacy and pricing. The Credo's commercial value was demonstrated most vividly in the 1982 Tylenol recall, which rebuilt market share within a year of the crisis.